# A Window of Opportunity Study of KTN3379 in Surgically Resectable Head and Neck Cancer Patients

> **NCT02473731** · PHASE1 · COMPLETED · sponsor: **Celldex Therapeutics** · enrollment: 12 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck

## Interventions

- **BIOLOGICAL:** KTN3379

## Key facts

- **NCT ID:** NCT02473731
- **Lead sponsor:** Celldex Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-09-22
- **Final completion:** 2016-10-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02473731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02473731, "A Window of Opportunity Study of KTN3379 in Surgically Resectable Head and Neck Cancer Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02473731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*